Dr. Brigitte C Widemann M.D.
Hematologist (Pediatric) | Pediatric Hematology-Oncology
8906 Bradmoor Dr Bethesda MD, 20817About
Dr. Brigitte Widemann is a pediatric hematologist practicing in Bethesda, MD. Dr. Widemann specializes in treating children that have a blood disease or cancer. Such blood diseases include disorders of red blood cells, white blood cells and/or platelets. The types of cancers that Dr. Widemann treats include leukemias, lymphomas and certain tumors. Dr. Widemann can also treat bleeding disorders in children. Pediatric hematologists can be found in childrens hospitals, community hospitals, university medical centers and more.
Education and Training
Universitaet Koeln 1988
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Meeting report: pharmacology in pediatric oncology. Summary of the 10th international expert meeting of the Kind Philipp Foundation for leukemia research, June 10 - 13, 2001 at the Schloss Reisensburg, Günzburg an der donau.
- Evaluation and treatment of fever in the non-neutropenic child with cancer.
- Merlin PAKs a punch.
- NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight.
- Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas.
- Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1.
- Characteristics and outcome of pediatric patients enrolled in phase I oncology trials.
- Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
- Sorafenib and sunitinib.
- Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas.
- Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group.
- Pediatric phase I trial design using maximum target inhibition as the primary endpoint.
- Experiences of families with a child, adolescent, or young adult with neurofibromatosis type 1 and plexiform neurofibroma evaluated for clinical trials participation at the National Cancer Institute.
- The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates.
- Phase I trial of pegylated interferon-alpha-2b in young patients with plexiform neurofibromas.
Dr. Brigitte C Widemann M.D.'s Practice location
Dr. Brigitte C Widemann M.D.'s reviews
Write ReviewRecommended Articles
- Stay Strong, Live Long: The Best Healthy Foods
There is a general consensus that foods are either tasty or healthy, but never both. That's simply not true. Many of us have got into a habit of eating something that is quick. Usually processed. This isn't not a good idea. What can be quicker than washing a few veggies, or a handful of berries and...
- Is Pleurisy Fatal?
What is pleurisy?Also known as pleuritis, is a condition that occurs when the pleural membranes lining the lungs and the inner aspect of the chest wall becomes inflamed, which causes them to rub against each other with friction during breathing.Pleurisy makes breathing difficult and painful. It is...
- Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant Recipients
Lymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...
- Purpura
PurpuraPurpura refers to purple-colored spots that are usually seen on the skin, including mucous membranes and other organs. It is also called skin hemorrhages or blood spots.Purpura is usually recognized when there is pooling of blood under the skin due to ruptured small blood vessels. The size of...
- How Is Leukemia Diagnosed?
Leukemia in its early stages may present no signs or symptoms, as these only appear when the leukemia cells have taken over a large number of normal blood cells. A person with leukemia is very lucky indeed if early-stage detection occurs incidentally, through a routine blood test or one done for...
- Potential Causes of Leukopenia
IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...